Silence Therapeutics plc Cost Of Sales
Silence Therapeutics plc (SLNCF) reported Cost Of Sales of GBP 10.32 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-03-13.
Discontinued › Expense Statement
ifrs-full:CostOfSales · last filed 2024-03-13
| Period end | Cost Of Sales 12 month |
|---|---|
| 2023-12-31 | 10.32M GBP 20-F · filed 2024-03-13 |
| 2022-12-31 | 10.88M GBP 20-F · filed 2024-03-13 |
| 2021-12-31 | 7.46M GBP 20-F · filed 2024-03-13 |
| 2020-12-31 | 3.76M GBP 20-F · filed 2023-03-15 |